<DOC>
	<DOCNO>NCT00777257</DOCNO>
	<brief_summary>The purpose study evaluate immunogenicity safety concomitant administration Menactra® vaccine Tdap vaccine adolescent age 11 17 year . Primary Objective : To determine whether concomitant administration two vaccine , Tdap Menactra® , induce antibody response similar observe vaccine give separately . Secondary Objective : To compare rate injection site reaction Tdap injection site Tdap Menactra® vaccine administer concomitantly correspond rate reaction Tdap vaccine administer alone .</brief_summary>
	<brief_title>Study Menactra® US Adolescents When Administered Concomitantly With Tdap Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Tetany</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Healthy determine medical history physical examination . Aged ≥ 11 17 year time study vaccination Day 0 . Informed consent form approve Institutional Review Board ( IRB ) sign parent legal guardian . Informed assent form approve IRB sign subject . Subject ( female ) agree use measure prevent pregnancy study . Exclusion Criteria : Serious chronic disease ( i.e . cardiac , renal , neurologic , metabolic , rheumatologic , psychiatric , etc. ) . Known suspected impairment immunologic function . Acute medical illness without fever within last 72 hour oral temperature ≥ 100.4°F ( ≥ 38.0°C ) time enrolment . History document invasive meningococcal disease previous meningococcal vaccination . History document infection Bordetella pertussis , Clostridium tetani , Corynebacterium diphtheriae vaccination tetanus , diphtheria pertussis vaccine within previous 5 year . Received either immune globulin blood product within last 3 month ; receive injected oral corticosteroid , immunomodulator therapy , within 6 week study vaccine . Individuals taper dose schedule oral steroid last &lt; 7 day individual ( e.g. , asthmatic ) short schedule oral steroid last 3 4 day may include trial long receive one course within last 2 week prior enrolment . Received antibiotic therapy within 72 hour prior vaccination Day 0 . Received vaccine 28 day prior 1st study vaccination schedule receive vaccination course study . Suspected known hypersensitivity either two study vaccine component . Unavailable entire study period , unable attend schedule visit comply study procedure . Enrolled another clinical trial . Diagnosed condition , , opinion investigator , would pose health risk subject interfere evaluation vaccine . For female , positive equivocal urine pregnancy test time study vaccination . Nursing mother .</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Meningitis</keyword>
	<keyword>Meningococcemia</keyword>
	<keyword>Pertussis</keyword>
	<keyword>Neisseria meningitidis</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Diphtheria</keyword>
</DOC>